CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-15 | BAKER BROS. ADVISORS LP Director | Grant or award · Share Option (Right to Buy) | +53,950 | 53,950 | ||
| 2023-06-15 | BAKER BROS. ADVISORS LP Director | Grant or award · Share Option (Right to Buy) | +53,950 | 53,950 | ||
| 2023-06-15 | Yi Qingqing Director | Grant or award | +12,922 | 29,614 | ||
| 2023-06-15 | Yi Qingqing Director | Grant or award · Share Option (Right to Buy) | +26,975 | 26,975 | ||
| 2023-06-14 | HHLR ADVISORS, LTD. 10% owner | Sale | −273,728 | $207.72 | $56.9M | 142,888,241 |
| 2023-06-13 | HHLR ADVISORS, LTD. 10% owner | Sale | −611,000 | $211.45 | $129.2M | 143,475,369 |
| 2023-06-13 | HHLR ADVISORS, LTD. 10% owner | Sale | −313,400 | $128.43 | $40.3M | 143,161,969 |
| 2023-06-12 | HHLR ADVISORS, LTD. 10% owner | Sale | −281,400 | $130.83 | $36.8M | 145,055,181 |
| 2023-06-12 | HHLR ADVISORS, LTD. 10% owner | Sale | −968,812 | $213.91 | $207.2M | 144,086,369 |
| 2023-06-09 | HHLR ADVISORS, LTD. 10% owner | Sale | −213,700 | $130.35 | $27.9M | 145,665,533 |
| 2023-06-09 | HHLR ADVISORS, LTD. 10% owner | Sale | −328,952 | $217.02 | $71.4M | 145,336,581 |
| 2023-06-08 | HHLR ADVISORS, LTD. 10% owner | Sale | −1,163,825 | $218.14 | $253.9M | 145,879,233 |
| 2023-06-07 | Wang Lai Global Head of R&D | Sale | −74 | $223.23 | $17K | 388 |
| 2023-06-07 | Wang Lai Global Head of R&D | Sale | −161 | $224.04 | $36K | 227 |
| 2023-06-07 | Wang Lai Global Head of R&D | Sale | −111 | $225.27 | $25K | 116 |
| 2023-06-07 | Wang Lai Global Head of R&D | Sale | −116 | $226.15 | $26K | 0 |
| 2023-06-07 | Wu Xiaobin President, COO & GM China | Sale | −531 | $223.23 | $119K | 2,760 |
| 2023-06-07 | Wu Xiaobin President, COO & GM China | Sale | −1,147 | $224.04 | $257K | 1,613 |
| 2023-06-07 | Wu Xiaobin President, COO & GM China | Sale | −789 | $225.27 | $178K | 824 |
| 2023-06-07 | Wu Xiaobin President, COO & GM China | Sale | −824 | $226.15 | $186K | 0 |
Page 44 of 71 · 1,406 trades